Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Feb 7, 2015; 21(5): 1457-1467
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1457
Table 2 Clinicopathologic characteristics of colorectal cancer patients with loss of CDX2 expression n (%)
ParametersCDX2-retained671 (94.1)Loss of CDX2 expression42 (5.9)P value
Age (median)60.9 ± 11.562.2 ± 12.10.5031
Sex0.070
Male414 (61.7)20 (47.6)
Female257 (38.1)22 (52.4)
Location< 0.001
Proximal colon166 (24.7)25 (59.5)
Distal colon276 (41.1)10 (23.8)
Rectum229 (34.1)7 (16.7)
Gross type0.009
Fungating451 (67.2)20 (47.6)
Ulcerative220 (32.8)22 (52.4)
T category0.005
T1, 2135 (20.1)1 (2.4)
T3, 4536 (79.9)41 (97.6)
N category< 0.001
N0355 (52.9)10 (23.8)
N1, 2316 (47.1)32 (76.2)
M category0.039
M0562 (83.8)30 (71.4)
M1109 (16.2)12 (28.6)
Stage< 0.001
I, II331 (49.3)9 (21.4)
III, IV340 (50.7)33 (78.6)
Adjuvant chemotherapy0.854
Not treated233 (34.7)14 (33.3)
Treated438 (65.3)28 (66.7)